Breaking News Instant updates and real-time market news.

MRVL

Marvell

$23.27

-0.11 (-0.47%)

, CAVM

Cavium

$87.56

-0.04 (-0.05%)

06:52
11/29/17
11/29
06:52
11/29/17
06:52

Jefferies sees 'multiple tailwinds' for Marvell, ups target to $28

Jefferies analyst Mark Lipacis raised his price target for Marvell Technology to $28 from $27 citing the company's October quarter beat and raised January quarter outlook. The analyst sees "multiple tailwinds" across Marvell's segments as a standalone entity, and continues to expect the acquisition of Cavium (CAVM) to create scale and be revenue synergistic. Lipacis keeps a Buy rating on Marvell in a research note titled "Marvellous Execution--Beats & Raises."

MRVL

Marvell

$23.27

-0.11 (-0.47%)

CAVM

Cavium

$87.56

-0.04 (-0.05%)

  • 29

    Nov

MRVL Marvell
$23.27

-0.11 (-0.47%)

11/29/17
LOOP
11/29/17
NO CHANGE
Target $28
LOOP
Buy
Marvell starting to 'hit on all cylinders', says Loop Capital
Loop Capital analyst Betsy Van Hees raised her price target on Marvell (MRVL) to $28 from $26 and kept her Buy rating following another earnings beat in Q3 and above-consensus outlook for Q4. Van Hees says the company stands to benefit from product cycles in Networking and Connectivity, increasing SSD demand, and leverage in the model in FY19 and FY20. The analyst adds that the Cavium (CAVM) acquisition will offer Marvell increased scale, broader product diversification, and EPS accretion.
11/28/17
FBCO
11/28/17
NO CHANGE
Target $30
FBCO
Outperform
Marvell price target raised to $30 from $22 at Credit Suisse
Credit Suisse analyst John Pitzer raised his price target for Marvell (MRVL) to $30 from $22 ahead of results. Earnings should be a mostly neutral event with investors focus on the Cavium (CAVM) acquisition, the analyst notes. Pitzer reiterates an Outperform rating on Marvell's shares.
11/27/17
BMOC
11/27/17
NO CHANGE
Target $25
BMOC
Market Perform
Marvell price target raised to $25 from $16 at BMO Capital
BMO Capital analyst Ambrish Srivastava raised his price target on Marvell (MRVL) to $25 in the wake of its Cavium (CAVM) acquisition, saying the deal makes sense since the combined entity will have greater earnings power as smaller companies find it increasingly more challenging to compete. Srivastava says that while there is some overlap between the two entities, there are enough businesses that complement each other, allowing for better positioning relative to Broadcom (AVGO). The analyst keeps his Market Perform rating on Marvell.
11/27/17
COWN
11/27/17
NO CHANGE
Target $29
COWN
Outperform
Despite rally, Marvell still has 30% upside potential, says Cowen
Cowen analyst Karl Ackerman said now that the Cavium (CAVM) deal is on the tape, the next step for Marvell (MRVL) is to execute on its earnings forecasts. The analyst believes that despite its recent rally, Marvell shares are one of the few semiconductor names that still have 30% upside potential. He sees potential opportunities in both storage and networking. Ackerman calls Marvell a Best Idea for 2018 and reiterated his Outperform rating and $29 price target on the shares.
CAVM Cavium
$87.56

-0.04 (-0.05%)

TODAY'S FREE FLY STORIES

11:25
11/20/18
11/20
11:25
11/20/18
11:25
Conference/Events
RBC Capital chemicals analyst to hold a group luncheon »

Chemicals Analyst…

11:25
11/20/18
11/20
11:25
11/20/18
11:25
Conference/Events
RBC Capital banking analyst to hold a group luncheon »

Group Luncheon, where…

TGT

Target

$70.14

-6.99 (-9.06%)

, KSS

Kohl's

$65.26

-5.49 (-7.76%)

11:21
11/20/18
11/20
11:21
11/20/18
11:21
OnTheFly
Target, Kohl’s slide after quarterly results amid concerns about holiday season »

Shares of Target (TGT)…

TGT

Target

$70.14

-6.99 (-9.06%)

KSS

Kohl's

$65.26

-5.49 (-7.76%)

BBY

Best Buy

$64.90

2.71 (4.36%)

AMZN

Amazon.com

$1,519.79

8.12 (0.54%)

WMT

Walmart

$94.20

-2.6 (-2.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 28

    Nov

  • 04

    Dec

  • 05

    Dec

  • 03

    Mar

CVE

Cenovus Energy

$7.64

-0.39 (-4.86%)

11:20
11/20/18
11/20
11:20
11/20/18
11:20
Options
Call spreads in Cenovus Energy as shares fall 4.6% »

Call spreads in Cenovus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
11/20/18
11/20
11:17
11/20/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$88.76

-2.58 (-2.82%)

11:16
11/20/18
11/20
11:16
11/20/18
11:16
Recommendations
Lowe's analyst commentary  »

Investors should step…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
11/20/18
11/20
11:16
11/20/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
11/20/18
11/20
11:15
11/20/18
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

11:15
11/20/18
11/20
11:15
11/20/18
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

TC

TuanChe

$0.00

(0.00%)

11:14
11/20/18
11/20
11:14
11/20/18
11:14
Syndicate
TuanChe opens at $7.50, IPO priced at $7.80 per share »

TuanChe (TC) priced 2.6M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BDIMF

Black Diamond Group

$0.00

(0.00%)

11:12
11/20/18
11/20
11:12
11/20/18
11:12
Conference/Events
Black Diamond Group management to meet with Raymond James »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BBY

Best Buy

$64.08

1.89 (3.04%)

11:10
11/20/18
11/20
11:10
11/20/18
11:10
Options
Best Buy puts active as shares see relative strength »

Best Buy puts active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 05

    Dec

AAPL

Apple

$179.47

-6.33 (-3.41%)

, AMZN

Amazon.com

$1,505.00

-6.67 (-0.44%)

11:06
11/20/18
11/20
11:06
11/20/18
11:06
Hot Stocks
White House asks for comment on possible emerging technology export restrictions »

In an advance notice of…

AAPL

Apple

$179.47

-6.33 (-3.41%)

AMZN

Amazon.com

$1,505.00

-6.67 (-0.44%)

GOOGL

Alphabet Class A

$1,027.00

0.77 (0.08%)

GOOG

Alphabet

$1,018.84

-0.16 (-0.02%)

IBM

IBM

$118.62

-1.75 (-1.45%)

FB

Facebook

$133.10

1.48 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 28

    Nov

  • 04

    Dec

  • 04

    Dec

  • 03

    Mar

AMZN

Amazon.com

$1,501.81

-9.86 (-0.65%)

11:04
11/20/18
11/20
11:04
11/20/18
11:04
Technical Analysis
Technical Take: Amazon.com hits highs of the session »

The shares of Amazon.com…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

OKTA

Okta

$47.47

-1.17 (-2.41%)

11:03
11/20/18
11/20
11:03
11/20/18
11:03
Hot Stocks
Okta continues expansion of API gateway partner ecosystem »

Okta announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Jan

AJG

Arthur J. Gallagher

$77.73

-0.6 (-0.77%)

11:02
11/20/18
11/20
11:02
11/20/18
11:02
Hot Stocks
Arthur J. Gallagher acquires JP Tech Insurance Services, terms not disclosed »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNR

Denbury Resources

$2.29

-0.155 (-6.34%)

11:00
11/20/18
11/20
11:00
11/20/18
11:00
Options
2-strike put buyers in Denbury Resources as shares drop 9.3% »

2-strike put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:00
11/20/18
11/20
11:00
11/20/18
11:00
General news
Atlanta Fed's Q4 GDPNow estimate was cut to 2.5% »

Atlanta Fed's Q4…

DB

Deutsche Bank

$9.38

-0.39 (-3.99%)

, DNSKY

Danske Bank

$0.00

(0.00%)

10:56
11/20/18
11/20
10:56
11/20/18
10:56
Periodicals
Deutsche finds $150B of suspicious flows tied to Danske, WSJ reports »

Deutsche Bank's (DB)…

DB

Deutsche Bank

$9.38

-0.39 (-3.99%)

DNSKY

Danske Bank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NURO

NeuroMetrix

$0.98

-0.02 (-2.00%)

10:53
11/20/18
11/20
10:53
11/20/18
10:53
Hot Stocks
NeuroMetrix issued new U.S. patent for Quell wearable technology »

NeuroMetrix announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

X

U.S. Steel

$26.42

-0.86 (-3.15%)

10:50
11/20/18
11/20
10:50
11/20/18
10:50
Options
US Steel sees put buying as shares drop 4.4% »

US Steel sees put buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$5.98

-0.075 (-1.24%)

10:47
11/20/18
11/20
10:47
11/20/18
10:47
Periodicals
Snap soon to debut new, higher-priced Spectacles with two cameras, Cheddar says »

Snap is looking to debut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 28

    Nov

TLSA

Tiziana Therapeutics

$0.00

(0.00%)

10:45
11/20/18
11/20
10:45
11/20/18
10:45
Syndicate
Tiziana Therapeutics opens at $10.50, IPO priced at $9.90 »

Tiziana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BE

Bloom Energy

$14.00

-0.5 (-3.45%)

10:45
11/20/18
11/20
10:45
11/20/18
10:45
Conference/Events
Bloom Energy has a conference call hosted by JPMorgan »

JPMorgan Analyst Coster…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 05

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$264.96

-4.32 (-1.60%)

10:42
11/20/18
11/20
10:42
11/20/18
10:42
Technical Analysis
Technical Take: SPDR S&P 500 ETF breaks back above $265 »

The SPDR S&P 500 ETF…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$264.96

-4.32 (-1.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.